APV Pharmaceutical Biotechnology specialist group meets on May 7th, 2025 at Valicare GmbH
Dr. Hans-Georg Eckert, Managing Director of Valicare GmbH and head of the APV specialist group (FG) Pharmaceutical Biotechnology, invited the members of the FG, other guests and the local APV group (Rhine/Neckar) to an F2F meeting at Valicare's offices.
The meeting will focus on 2 main topics for discussion.
Contamination control strategy for advanced therapy medicinal products (ATMPs) and the required switch to DEHP-free primary packaging material for manufacturers of pharmaceutical products.
In addition, Dr. Eckert will invite customers from the pharmaceutical sector in Frankfurt to give a specialist presentation from the perspective of a company.
The International Association for Pharmaceutical Technology (APV) is an internationally orientated, interdisciplinary, independent professional society for pharmaceutical technology and industrial pharmacy.
“Our goal is to deepen scientific and practical knowledge in the development, manufacturing, analytics, quality assurance, distribution, and use of pharmaceuticals and medical products, and to disseminate this knowledge within professional circles so that effective and safe products continue to be available for patient healthcare.“
The APV focuses on networking and the interdisciplinary exchange of knowledge within and between the various specialist groups (FG).
The focus group Pharmaceutical Biotechnology represents pharmaceutical biotechnology, which involves the production and application of medicinal products or medical devices using organisms or parts thereof, within the APV.
The FG of Pharmaceutical Biotechnology deals with the production and application of pharmaceuticals or medical products produced by organisms or parts thereof. Information on the main areas of work, current projects and publications can be found here: APV Mainz: Pharmaceutical Biotechnology
Valicare is a subsidiary of Syntegon Technology, a leading manufacturer of pharmaceutical process and primary filing technology. As a GMP service provider based in Frankfurt, Valicare has successfully executed more than 5,000 GMP projects for the pharmaceutical and biotechnology industry worldwide since founding in 2002.